NCT04264130View on ClinicalTrials.gov

Effect of Artemisinin-based Combination Therapies on Schistosomiasis on Malaria Co-infection

PHASE2CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

July 31, 2018

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Schistosomiasis Haematobia
Interventions
DRUG

Artesunate-Pyronaridine

Subjects received artesunate-pyronaridine according to their body weight once per day for three days.

DRUG

Artemether-Lumefantrine

subjects received artemether-lumefantrine according to their body weight twice per day for three days.

DRUG

Artefenomel-Ferroquine

Subject received a single dose of artefenomel-ferroquine according to their body weight

Trial Locations (1)

242

Centre de Recherches Medicales de Lambarene, Lambaréné

All Listed Sponsors
lead

Centre de Recherche Médicale de Lambaréné

OTHER

NCT04264130 - Effect of Artemisinin-based Combination Therapies on Schistosomiasis on Malaria Co-infection | Biotech Hunter | Biotech Hunter